Legend Biotech earnings missed by $0.13, revenue topped estimates
AI Summary
Legend Biotech reported earnings that missed estimates by $0.13, while revenue topped expectations. The headline does not provide additional financial details.
Related Articles
ASX set to fall, AI stocks drive Wall Street higher
The Sydney Morning Herald —
Loot boxes, influencers, and addictive features face an EU crackdown
The Verge —
Ternium weighs more anti-dumping cases as steel snarls trade talks with US
Investing.com —
Earnings call transcript: Technoprobe Q3 2026 sales surge on AI demand
Investing.com —
DCIL reports Q2 profitability turnaround with PAT ₹7.31 crore
The Hindu —
Analysis: Is Nvidia too big to fail? Its AI financing web raises the stakes
CNBC —